+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Seborrheic Dermatitis Global Market Report 2024

  • PDF Icon

    Report

  • 175 Pages
  • February 2024
  • Region: Global
  • The Business Research Company
  • ID: 5933970
The seborrheic dermatitis market size has grown rapidly in recent years. It will grow from $2.46 billion in 2023 to $2.76 billion in 2024 at a compound annual growth rate (CAGR) of 11.9%. The growth observed during the historic period can be attributed to several factors, including advancements in diagnosis and increased awareness, a growing aging population, lifestyle factors influencing dermatological conditions, advancements in dermatology, and consumer preferences favoring cosmetic solutions.

The seborrheic dermatitis market size is expected to see rapid growth in the next few years. It will grow to $4.14 billion in 2028 at a compound annual growth rate (CAGR) of 10.7%. The anticipated growth in the forecast period can be attributed to a heightened focus on natural and herbal products, supportive regulatory measures for new therapies, global health preparedness initiatives, and increased patient advocacy and support. Major trends expected during the forecast period include the integration of dermatological technologies, ongoing research on the role of the microbiome in dermatology, the development of customized treatment plans, the widespread adoption of telemedicine and e-health solutions, and continuous technological innovations in skincare.

The prevalence of dermatological diseases is on the rise, contributing to the anticipated growth of the seborrheic dermatitis market. Dermatological diseases encompass various medical conditions that affect the skin, hair, nails, and mucous membranes. Treating these conditions not only provides relief from discomfort but also improves skin appearance and helps prevent complications such as infections or scarring, thereby significantly enhancing affected individuals' overall quality of life. For instance, as per data from the National Psoriasis Foundation in December 2022, an estimated 125 million people worldwide, constituting approximately 2-3% of the global population, were affected by psoriasis - a type of dermatological disease. In the United States alone, over 8 million individuals were reported to have psoriasis in 2022. Hence, the increasing prevalence of dermatological diseases is expected to fuel the growth of the seborrheic dermatitis market.

The seborrheic dermatitis market is expected to witness expansion driven by the escalating healthcare expenditure. This expenditure refers to the total spending on healthcare-related goods and services within a healthcare system or economy. For seborrheic dermatitis, healthcare expenditure encompasses costs linked with diagnosis, management, and treatment. It encompasses various medical services, therapies, and supportive systems allocated to patients affected by the condition. For example, according to the Canadian Institute for Health Information in November 2022, healthcare expenditure increased by 8% - amounting to $331 billion in 2022 compared to 7.6% in 2021. Consequently, the surge in healthcare expenditure is a significant driver fueling the growth of the seborrheic dermatitis market.

The market's growth may face obstacles due to the high cost associated with pharmacologic treatment options. The elevated expenses linked to these treatments create a barrier for numerous patients, sparking discussions about healthcare affordability, insurance coverage, and initiatives aimed at reducing drug prices. The considerable cost of pharmacologic treatments poses challenges for individuals affected by seborrheic dermatitis, impacting their access to suitable remedies and potentially leading to dissatisfaction with their ongoing treatment regimens. For instance, CostHelper Inc. reported in 2023 that prescription-strength antifungal and anti-inflammatory medications could surpass the costs of mild corticosteroids, while over-the-counter shampoos and topical therapies for seborrheic dermatitis often amount to less than $20 per month. Thus, the high cost of pharmacologic treatment options acts as a hindrance to the seborrheic dermatitis market's growth.

Leading companies in the seborrheic dermatitis market are dedicating efforts to pioneer innovative and more efficacious medical therapies, such as roflumilast foam, to drive market revenues. Roflumilast foam represents a novel, daily-use topical treatment specifically designed for inflammatory skin conditions in hair-bearing areas such as the scalp, face, and trunk. For example, Arcutis Biotherapeutics Inc., a US-based medical dermatology company, introduced roflumilast foam 0.3% in April 2023 as the first topical drug with a unique mechanism of action for seborrheic dermatitis approved by the Food and Drug Administration (FDA) in over two decades. This investigational formulation is a once-daily, topical treatment containing a highly potent and selective phosphodiesterase type 4 (PDE4) inhibitor, designed to address inflammatory dermatoses, particularly in hair-bearing areas, for individuals aged nine years and older.

In September 2022, Arcutis Biotherapeutics Inc., a medical dermatology company based in the United States, successfully acquired Ducentis BioTherapeutics Ltd. for an approximate sum of $30 million. This strategic move by Arcutis Biotherapeutics aims to enhance its product pipeline and capitalize on the specialized expertise and capabilities of Ducentis BioTherapeutics. The acquisition is geared towards the development, manufacturing, and commercialization of therapies that address unmet needs in the field of dermatology. Ducentis BioTherapeutics Ltd., based in the United Kingdom, is a biotechnology company known for its focus on innovative treatments for various dermatological conditions, including psoriasis, atopic dermatitis, seborrheic dermatitis, and hand eczema.

Major companies operating in the seborrheic dermatitis market report are Pfizer Inc., Johnson and Johnson, Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb Co, Abbott Laboratories, GlaxoSmithKline Plc, Acella Pharmaceuticals LLC, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Galderma S.A., Dr. Reddy's Laboratories Ltd., Cipla Limited, Getinge AB, Hikma Pharmaceuticals plc, Amneal Pharmaceuticals LLC, Lupin Limited, Monarch Pharmachem, Alliance Pharma plc, Genentech Inc., Zydus Group, Arcutis Biotherapeutics Inc.

North America was the largest region in the seborrheic dermatitis market in 2023. The regions covered in the seborrheic dermatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the seborrheic dermatitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The seborrheic dermatitis market consists of revenues earned by entities by providing services, including photodynamic therapy and light therapy combinations. The market value includes the value of related goods sold by the service provider or included within the service offering. The seborrheic dermatitis market also includes sales of topical steroids, and calcineurin inhibitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The main types of treatment for seborrheic dermatitis encompass anti-inflammatory, antifungal, corticosteroid lotions, sulfur products, and others. Anti-inflammatory treatments are designed to alleviate inflammation, a common symptom in various dermatological conditions. Diagnoses may involve physical examination, biopsy, and other methods, and treatment can take various dosage forms such as creams, shampoos, ointments, gels, among others. Administration routes may include oral, topical, parenteral, and others. These treatments find application across diverse end-users, including hospitals, specialty clinics, homes, and other healthcare settings.

The seborrheic dermatitis market research report is one of a series of new reports that provides seborrheic dermatitis market statistics, including seborrheic dermatitis industry global market size, regional shares, competitors with a seborrheic dermatitis market share, detailed seborrheic dermatitis market segments, market trends, and opportunities, and any further data you may need to thrive in the seborrheic dermatitis industry. This seborrheic dermatitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Seborrheic Dermatitis Market Characteristics3. Seborrheic Dermatitis Market Trends and Strategies
4. Seborrheic Dermatitis Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Seborrheic Dermatitis Market Size and Growth
5.1. Global Seborrheic Dermatitis Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Seborrheic Dermatitis Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Seborrheic Dermatitis Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Seborrheic Dermatitis Market Segmentation
6.1. Global Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Anti-Inflammatory
  • Antifungal
  • Corticosteroid Lotions
  • Sulfur Products
  • Other Treatments
6.2. Global Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Physical Examination
  • Biopsy
  • Other Diagnoses
6.3. Global Seborrheic Dermatitis Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Creams
  • Shampoos
  • Ointments
  • Gels
  • Other Dosage Forms
6.4. Global Seborrheic Dermatitis Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Topical
  • Parenteral
  • Other Route of Administrations
6.5. Global Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Other End-Users
7. Seborrheic Dermatitis Market Regional and Country Analysis
7.1. Global Seborrheic Dermatitis Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Seborrheic Dermatitis Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Seborrheic Dermatitis Market
8.1. Asia-Pacific Seborrheic Dermatitis Market Overview
Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Seborrheic Dermatitis Market
9.1. China Seborrheic Dermatitis Market Overview
9.2. China Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Seborrheic Dermatitis Market
10.1. India Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Seborrheic Dermatitis Market
11.1. Japan Seborrheic Dermatitis Market Overview
11.2. Japan Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Seborrheic Dermatitis Market
12.1. Australia Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Seborrheic Dermatitis Market
13.1. Indonesia Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Seborrheic Dermatitis Market
14.1. South Korea Seborrheic Dermatitis Market Overview
14.2. South Korea Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Seborrheic Dermatitis Market
15.1. Western Europe Seborrheic Dermatitis Market Overview
15.2. Western Europe Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Seborrheic Dermatitis Market
16.1. UK Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Seborrheic Dermatitis Market
17.1. Germany Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Seborrheic Dermatitis Market
18.5. France Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Seborrheic Dermatitis Market
19.9. Italy Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Seborrheic Dermatitis Market
20.13. Spain Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Seborrheic Dermatitis Market
21.1. Eastern Europe Seborrheic Dermatitis Market Overview
21.2. Eastern Europe Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Seborrheic Dermatitis Market
22.1. Russia Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Seborrheic Dermatitis Market
23.1. North America Seborrheic Dermatitis Market Overview
23.2. North America Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Seborrheic Dermatitis Market
24.1. USA Seborrheic Dermatitis Market Overview
24.2. USA Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Seborrheic Dermatitis Market
25.1. Canada Seborrheic Dermatitis Market Overview
25.2. Canada Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Seborrheic Dermatitis Market
26.1. South America Seborrheic Dermatitis Market Overview
26.2. South America Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Seborrheic Dermatitis Market
27.1. Brazil Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Seborrheic Dermatitis Market
28.1. Middle East Seborrheic Dermatitis Market Overview
28.2. Middle East Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Seborrheic Dermatitis Market
29.1. Africa Seborrheic Dermatitis Market Overview
29.2. Africa Seborrheic Dermatitis Market, Segmentation by Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Seborrheic Dermatitis Market, Segmentation by Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Seborrheic Dermatitis Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Seborrheic Dermatitis Market Competitive Landscape and Company Profiles
30.1. Seborrheic Dermatitis Market Competitive Landscape
30.2. Seborrheic Dermatitis Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Johnson and Johnson
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Merck and Co. Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. AbbVie Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Bayer AG
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Seborrheic Dermatitis Market Other Major and Innovative Companies
31.1. Novartis AG
31.2. Sanofi S.a.
31.3. Bristol Myers Squibb Co
31.4. Abbott Laboratories
31.5. GlaxoSmithKline Plc
31.6. Acella Pharmaceuticals LLC
31.7. Eli Lilly and Company
31.8. Amgen Inc.
31.9. Boehringer Ingelheim International GmbH
31.10. Viatris Inc.
31.11. Baxter International Inc.
31.12. Teva Pharmaceutical Industries Ltd.
31.13. Sun Pharmaceutical Industries Ltd.
31.14. Galderma S.a.
31.15. Dr. Reddy's Laboratories Ltd.
32. Global Seborrheic Dermatitis Market Competitive Benchmarking33. Global Seborrheic Dermatitis Market Competitive Dashboard34. Key Mergers and Acquisitions in the Seborrheic Dermatitis Market
35. Seborrheic Dermatitis Market Future Outlook and Potential Analysis
35.1 Seborrheic Dermatitis Market in 2028 - Countries Offering Most New Opportunities
35.2 Seborrheic Dermatitis Market in 2028 - Segments Offering Most New Opportunities
35.3 Seborrheic Dermatitis Market in 2028 - Growth Strategies
35.3.1 Market Trend-based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

Seborrheic Dermatitis Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on seborrheic dermatitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for seborrheic dermatitis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:
1) By Treatment: Anti-Inflammatory; Antifungal; Corticosteroid Lotions; Sulfur Products; Other Treatments
2) By Diagnosis: Physical Examination; Biopsy; Other Diagnoses
3) By Dosage Form: Creams; Shampoos; Ointments; Gels; Other Dosage Forms
4) By Route Of Administration: Oral; Topical; Parenteral; Other Route Of Administrations
5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users

Key Companies Mentioned: Pfizer Inc.; Johnson and Johnson; Merck and Co. Inc.; AbbVie Inc.; Bayer AG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Methodology

Loading
LOADING...